198 related articles for article (PubMed ID: 33947423)
1. Complications of thoracoscopic talc insufflation for the treatment of malignant pleural effusions: a meta-analysis.
Zhang W; Zhao YL; Li SJ; Zhao YN; Guo NN; Liu B
J Cardiothorac Surg; 2021 May; 16(1):125. PubMed ID: 33947423
[TBL] [Abstract][Full Text] [Related]
2. Thoracoscopy talc poudrage : a 15-year experience.
de Campos JR; Vargas FS; de Campos Werebe E; Cardoso P; Teixeira LR; Jatene FB; Light RW
Chest; 2001 Mar; 119(3):801-6. PubMed ID: 11243960
[TBL] [Abstract][Full Text] [Related]
3. Talc pleurodesis: comparison of talc slurry instillation with thoracoscopic talc insufflation for malignant pleural effusions.
Debeljak A; Kecelj P; Triller N; Letonja S; Kern I; Debevec L; Rozman A
J BUON; 2006; 11(4):463-7. PubMed ID: 17309178
[TBL] [Abstract][Full Text] [Related]
4. Lung injury following thoracoscopic talc insufflation: experience of a single North American center.
Gonzalez AV; Bezwada V; Beamis JF; Villanueva AG
Chest; 2010 Jun; 137(6):1375-81. PubMed ID: 20097802
[TBL] [Abstract][Full Text] [Related]
5. [Thoracoscopic pleurodesis in malignant pleural effusions].
Mitrofan C; Aldea A; Grigorescu C; Jitaru I; Iosep G; Aramă A; Danciu CE; Bolog S; Mihăescu T
Rev Med Chir Soc Med Nat Iasi; 2005; 109(4):799-803. PubMed ID: 16612848
[TBL] [Abstract][Full Text] [Related]
6. Thoracoscopic talc insufflation versus talc slurry for symptomatic malignant pleural effusion.
Yim AP; Chan AT; Lee TW; Wan IY; Ho JK
Ann Thorac Surg; 1996 Dec; 62(6):1655-8. PubMed ID: 8957368
[TBL] [Abstract][Full Text] [Related]
7. Clinical efficacy and safety of thoracoscopic talc pleurodesis in malignant pleural effusions.
Kolschmann S; Ballin A; Gillissen A
Chest; 2005 Sep; 128(3):1431-5. PubMed ID: 16162739
[TBL] [Abstract][Full Text] [Related]
8. Pleurodesis for malignant pleural effusions.
Shaw P; Agarwal R
Cochrane Database Syst Rev; 2004; (1):CD002916. PubMed ID: 14973997
[TBL] [Abstract][Full Text] [Related]
9. Phase III intergroup study of talc poudrage vs talc slurry sclerosis for malignant pleural effusion.
Dresler CM; Olak J; Herndon JE; Richards WG; Scalzetti E; Fleishman SB; Kernstine KH; Demmy T; Jablons DM; Kohman L; Daniel TM; Haasler GB; Sugarbaker DJ; ; ; ;
Chest; 2005 Mar; 127(3):909-15. PubMed ID: 15764775
[TBL] [Abstract][Full Text] [Related]
10. Talc poudrage versus talc slurry in the treatment of malignant pleural effusion. A prospective comparative study.
Stefani A; Natali P; Casali C; Morandi U
Eur J Cardiothorac Surg; 2006 Dec; 30(6):827-32. PubMed ID: 17113008
[TBL] [Abstract][Full Text] [Related]
11. Thoracoscopic talc poudrage pleurodesis for malignant effusions. A review of 360 cases.
Viallat JR; Rey F; Astoul P; Boutin C
Chest; 1996 Dec; 110(6):1387-93. PubMed ID: 8989050
[TBL] [Abstract][Full Text] [Related]
12. Early and late morbidity and mortality and life expectancy following thoracoscopic talc insufflation for control of malignant pleural effusions: a review of 400 cases.
Barbetakis N; Asteriou C; Papadopoulou F; Samanidis G; Paliouras D; Kleontas A; Lyriti K; Katsikas I; Tsilikas C
J Cardiothorac Surg; 2010 Apr; 5():27. PubMed ID: 20403196
[TBL] [Abstract][Full Text] [Related]
13. Comparison of insufflated talc under thoracoscopic guidance with standard tetracycline and bleomycin pleurodesis for control of malignant pleural effusions.
Hartman DL; Gaither JM; Kesler KA; Mylet DM; Brown JW; Mathur PN
J Thorac Cardiovasc Surg; 1993 Apr; 105(4):743-7; discussion 747-8. PubMed ID: 7682268
[TBL] [Abstract][Full Text] [Related]
14. Effect of Thoracoscopic Talc Poudrage vs Talc Slurry via Chest Tube on Pleurodesis Failure Rate Among Patients With Malignant Pleural Effusions: A Randomized Clinical Trial.
Bhatnagar R; Piotrowska HEG; Laskawiec-Szkonter M; Kahan BC; Luengo-Fernandez R; Pepperell JCT; Evison MD; Holme J; Al-Aloul M; Psallidas I; Lim WS; Blyth KG; Roberts ME; Cox G; Downer NJ; Herre J; Sivasothy P; Menzies D; Munavvar M; Kyi MM; Ahmed L; West AG; Harrison RN; Prudon B; Hettiarachchi G; Chakrabarti B; Kavidasan A; Sutton BP; Zahan-Evans NJ; Quaddy JL; Edey AJ; Clive AO; Walker SP; Little MHR; Mei XW; Harvey JE; Hooper CE; Davies HE; Slade M; Sivier M; Miller RF; Rahman NM; Maskell NA
JAMA; 2020 Jan; 323(1):60-69. PubMed ID: 31804680
[TBL] [Abstract][Full Text] [Related]
15. A prospective, randomised study comparing the efficacy of talc slurry and bleomycin in the treatment of malignant pleural effusions.
Noppen M; Degreve J; Mignolet M; Vincken W
Acta Clin Belg; 1997; 52(5):258-62. PubMed ID: 9489119
[TBL] [Abstract][Full Text] [Related]
16. Safety and complications of medical thoracoscopy in the management of pleural diseases.
Wan YY; Zhai CC; Lin XS; Yao ZH; Liu QH; Zhu L; Li DZ; Li XL; Wang N; Lin DJ
BMC Pulm Med; 2019 Jul; 19(1):125. PubMed ID: 31291926
[TBL] [Abstract][Full Text] [Related]
17. [Medical thoracoscopic talc pleurodesis for malignant pleural effusion: an analysis of 27 cases].
Zhang W; Wang GF; Zhang H; Mu XD; Jin Z
Beijing Da Xue Xue Bao Yi Xue Ban; 2008 Dec; 40(6):600-2. PubMed ID: 19088831
[TBL] [Abstract][Full Text] [Related]
18. Thoracoscopic talc poudrage in malignant pleural effusions: effective pleurodesis despite low pleural pH.
Aelony Y; King RR; Boutin C
Chest; 1998 Apr; 113(4):1007-12. PubMed ID: 9554639
[TBL] [Abstract][Full Text] [Related]
19. The evidence on the effectiveness of management for malignant pleural effusion: a systematic review.
Tan C; Sedrakyan A; Browne J; Swift S; Treasure T
Eur J Cardiothorac Surg; 2006 May; 29(5):829-38. PubMed ID: 16626967
[TBL] [Abstract][Full Text] [Related]
20. Talc pleurodesis for the management of malignant pleural effusions in Japan.
Inoue T; Ishida A; Nakamura M; Nishine H; Mineshita M; Miyazawa T
Intern Med; 2013; 52(11):1173-6. PubMed ID: 23728550
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
